FDAnews
www.fdanews.com/articles/97441-tau-researcher-develops-alzheimer-rsquo-s-treatment

TAU Researcher Develops Alzheimer’s Treatment

August 21, 2007

According to Israel’s business daily Globes, a Tel Aviv University researcher is working on a nasal spray to combat Alzheimer’s.

Beka Solomon of TAU’s Molecular Microbiology and Biotechnology Department administers a harmless bacterial virus known as a filamentous phage through nasal passages to the brain where they lock onto plaques associated with Alzheimer’s, Globes reported.

According to the paper, Solomon treated mice with the phage, and found that mice exhibiting Alzheimer’s symptoms regained their sense of smell and demonstrated memory improvement. After one year of treatment, they had 80 percent fewer plaques than untreated mice.

The drug candidate is being commercialized through Ramot, the technology transfer company of Tel Aviv University, the paper added.